Phibro Animal Health (NASDAQ:PAHC) Raised to Neutral at BNP Paribas Exane
Phibro Animal Health (NASDAQ:PAHC – Get Free Report) was upgraded by investment analysts at BNP Paribas Exane from an “underperform” rating to a “neutral” rating in a research note issued to investors on Monday, Marketbeat.com reports. The brokerage presently has a $24.00 price objective on the stock. BNP Paribas Exane’s price objective points to a […]
Phibro Animal Health (NASDAQ:PAHC – Get Free Report) was upgraded by investment analysts at BNP Paribas Exane from an “underperform” rating to a “neutral” rating in a research note issued to investors on Monday, Marketbeat.com reports. The brokerage presently has a $24.00 price objective on the stock. BNP Paribas Exane’s price objective points to a […]
